* Update: AGN confirmed that it raised prices on 51 products, 27 by ~9.5% and 24 by ~4.9%. CEO Brent Saunders announced two years ago that the company would only hike prices once each year. It does not expect to pocket any additional monies from the increases considering the ever-increasing discounts and rebates to insurers, pharmacy benefit managers and government programs.
* Generic drug maker Hikma Pharmaceuticals (OTCPK:HKMPY) hiked the price of its morphine by 10%, anesthetic ketamine by 20% and blood pressure med enalaprilat by 30%. All three increases were less than $1 per vial according to CEO Steve Weiss, adding that the company reduced prices on some offerings.
*GlaxoSmithKline (GSK -1%) increased prices on 36 drugs, none more than 3%.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.